Literature DB >> 27681600

Early surgical treatment of retinal hemangioblastomas.

Koen A van Overdam1,2, Tom Missotten1, Emine Kilic3, Leigh H Spielberg1.   

Abstract

PURPOSE: To evaluate the clinical course after early surgical treatment with excision of retinal hemangioblastomas (RHs) before development of major complications.
METHODS: Interventional case series of four eyes (four patients) with a peripheral RH that had not yet been treated by laser or cryotherapy prior to surgery. All eyes underwent 23-gauge vitrectomy with lesion excision. One patient underwent ligation of the feeder vessel prior to lesion excision. Best-corrected visual acuity and clinical course were assessed during a follow-up period of at least 4 years.
RESULTS: Four patients (mean age 27.3 years; range 19-32) were included, of whom two had von Hippel-Lindau syndrome. Visual acuity improved in three patients (mean 4.8 lines; range 3-10) and remained stable at 0.0 logMAR in one patient. There were no intraoperative complications. Postoperative complications included transient mild vitreous haemorrhage (n = 2), and local epiretinal membrane formation at the excision location (n = 1). At 4 years postoperatively, there were no long-term complications. There was one case of a new lesion, which was effectively treated with laser.
CONCLUSION: Vitrectomy with RH excision seems to be an effective approach for larger RHs and could be considered an early treatment option in selected cases. Postoperative complications were limited in scope of this case series. Important points to consider during vitrectomy are effective closure of feeder and draining vessels as well as complete removal of posterior hyaloid and epiretinal membranes in order to avoid postoperative vitreous haemorrhage and proliferative vitreoretinopathy.
© 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diathermy forceps; feeder vessel ligation; lesion excision; pars plana vitrectomy; retinal hemangioblastoma; von Hippel-Lindau

Mesh:

Year:  2016        PMID: 27681600     DOI: 10.1111/aos.13223

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Classification and treatment follow-up of a juxtapapillary retinal hemangioblastoma with optical coherence tomography angiography.

Authors:  Lisette M Smid; Koen A van Overdam; Valentina Davidoiu; Jan H de Jong; Johannes F de Boer; Koenraad A Vermeer; Mirjam E J van Velthoven
Journal:  Am J Ophthalmol Case Rep       Date:  2019-05-20

2.  First-in-human study of the safety, effectiveness and ease of use of the intra-ocular diathermy forceps during vitrectomy.

Authors:  Koen van Overdam; Jerrel Pawiroredjo; Dinesh Jiawan; Sonia Manning
Journal:  Acta Ophthalmol       Date:  2019-05-14       Impact factor: 3.761

3.  Retinal haemangioblastomas in von Hippel-Lindau germline mutation carriers: progression, complications and treatment outcome.

Authors:  Anass Hajjaj; Koen A van Overdam; Rogier A Oldenburg; Anna E Koopmans; Ans M W van den Ouweland; Annelies de Klein; Emine Kiliç
Journal:  Acta Ophthalmol       Date:  2020-01-30       Impact factor: 3.761

4.  Intra-ocular diathermy forceps.

Authors:  Koen A van Overdam; Emine Kilic; Robert M Verdijk; Sonia Manning
Journal:  Acta Ophthalmol       Date:  2017-12-02       Impact factor: 3.761

5.  REPAIR OF COMBINED TRACTION-RHEGMATOGENOUS RETINAL DETACHMENT AFTER CRYOABLATION OF A RETINAL CAPILLARY HEMANGIOBLASTOMA.

Authors:  Philip J DeSouza; Craig M Greven
Journal:  Retin Cases Brief Rep       Date:  2022-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.